1 completed, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow GSK945237: new trials by email Literature Review of GSK945237 trials Research Report on GSK945237
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc. GSK945237, Placebo, Linezolid - Infections, Bacterial | Phase 1 | Withdrawn | GlaxoSmithKline | 2009-11-01 | 2015-04-22 | |
| To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects GSK945237, Sugar Pill - Healthy Subjects, Infections, Bacterial | Phase 1 | Completed | GlaxoSmithKline | 68 | 2007-07-01 | 2012-03-19 |
GlaxoSmithKline (2)
Australia (1)